Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)
Not Applicable
Completed
- Conditions
- Schizophrenia
- Interventions
- Drug: clozapine+haloperidolDrug: clozapine,electroconvulsive therapy
- Registration Number
- NCT00753051
- Lead Sponsor
- Khon Kaen University
- Brief Summary
Clozapine treatment resistant schizophrenia is still prevalent.The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determined.This study is a randomized control trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
- schizophrenic patients diagnosed with schedules for clinical assessment in neuropsychiatry ( SCAN )in accordance with DSM-IV-TR or ICD-10
- Resistant to at least 6 weeks of clozapine treatment in therapeutic dosage
- Voluntary to participate the research protocol expressed by signing informed consent form
Exclusion Criteria
- Patient does not volunteer himself or herself
- Patient is having epilepsy, DM, cardiac disease, autistic disorder and illiterate
- Patient is deaf, blind , dumb to obstruct good communication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1. clozapine+haloperidol clozapine as the main agent and it will be adjuncted by haloperidol 2. clozapine,electroconvulsive therapy clozapine as the main agent and it will be adjuncted by electroconvulsive therapy
- Primary Outcome Measures
Name Time Method PANSS , HAM-D , CGI , AIMS Scores every 4 weeks for 24 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Psychiatry.Faculty of Medicine.KhonKaen University.
🇹ðŸ‡Muang, KhonKaen, Thailand